Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 10, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | A | B | $42.28B | 26.10% | 1.00% | 3.95% | 2.60% | 19.74 | 2.54 | 83.90% | 1.40% | 4.06% |
| THC | TENET HEALTHCARE CORP | A | B | $16.96B | 33.60% | 4.70% | 10.67% | 11.70% | 5.16 | 1.71 | 100.00% | 6.50% | 12.72% |
| NBIX | NEUROCRINE BIOSCIENCES INC | A | B | $13.91B | 15.80% | 11.00% | 17.33% | 18.00% | 0.42 | 3.38 | 98.40% | 16.00% | 23.43% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | A | B | $10.03B | -9.30% | -3.20% | -5.54% | -7.00% | 1.87 | 1.65 | 88.50% | -8.90% | -12.10% |
| VISN | VISTANCE NETWORKS INC | A | B | $4.30B | -32.90% | 11.10% | 20.69% | 13.90% | -3.84 | 2.25 | 41.10% | 16.80% | 26.14% |
| INDV | INDIVIOR PLC | A | B | $4.23B | -69.60% | 11.60% | 65.63% | 86.80% | -7.84 | 0.96 | 82.90% | 14.10% | 25.06% |
| RSI | RUSH STREET INTERACTIVE INC | A | A | $4.06B | 28.90% | 6.30% | -17.56% | 415.80% | 2.40 | 1.91 | 35.10% | 2.80% | -6.82% |
| VCYT | VERACYTE INC | A | C | $2.90B | 2.50% | 2.30% | 2.39% | 15.10% | 0.09 | 6.23 | 68.50% | 6.10% | 6.26% |
| HCI | HCI GROUP INC | A | B | $2.08B | 31.90% | 8.80% | N/A | 17.70% | 1.82 | N/A | 63.20% | 25.00% | 35.53% |
| HLMN | HILLMAN SOLUTIONS CORP | A | C | $2.02B | 3.10% | 1.60% | 5.20% | 7.70% | 0.95 | 2.46 | 48.80% | 2.40% | 7.18% |
| FIVN | FIVE9 INC | A | C | $1.33B | 4.50% | 1.60% | 3.09% | 2.70% | 1.28 | 4.61 | 55.20% | 2.80% | 4.29% |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | A | B | $1.24B | 7.60% | 3.80% | 8.41% | 18.50% | 0.93 | 1.13 | 62.70% | 4.30% | 6.98% |
| TBLA | TABOOLACOM LTD | A | B | $1.01B | 2.60% | 1.60% | 4.47% | 16.70% | 0.68 | 1.06 | 30.40% | 1.30% | 2.53% |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | A | B | $857.17M | 28.00% | 4.10% | N/A | 6.30% | 5.24 | N/A | 33.60% | 7.70% | 10.65% |
| NRDS | NERDWALLET INC | A | A | $746.04M | 19.20% | 15.60% | 11.88% | 31.60% | 0.23 | 3.70 | 91.60% | 9.20% | 6.25% |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | A | A | $705.28M | 87.50% | 9.90% | 42.59% | 30.50% | 6.80 | 0.93 | 64.20% | 7.20% | 16.07% |
| LE | LANDS' END INC | A | C | $568.25M | 5.10% | 1.50% | 9.41% | 9.70% | 2.69 | 1.76 | 48.80% | 0.90% | 4.23% |
| ORGO | ORGANOGENESIS HOLDINGS INC | A | C | $486.07M | -5.40% | -2.80% | -1.98% | -2.60% | 0.49 | 3.32 | 74.50% | -2.90% | -1.79% |
| LTRX | LANTRONIX INC | A | B | $250.85M | -12.40% | -7.50% | -9.86% | -18.60% | 0.64 | 2.75 | 43.00% | -7.90% | -7.87% |
| ELMD | ELECTROMED INC | A | B | $230.28M | 18.70% | 15.50% | 24.42% | 38.80% | 0.20 | 5.09 | 78.00% | 12.40% | 16.54% |
| INFU | INFUSYSTEM HOLDINGS INC | A | A | $155.78M | 9.90% | 5.40% | 13.46% | 10.50% | 0.78 | 1.90 | 55.40% | 3.90% | 7.65% |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.